Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Approves New Indication for Kerendia

Pharmaceutical Executive Daily: FDA Approves New Indication for Kerendia

Published 2 months ago
Description
FDA approves Kerendia as the first new treatment for kidney disease in type 1 diabetes in decades, Novo, Roche, and Aethlon Medical strike major deals and mergers with Orbis Medicines, Dualitas Therapeutics, and North Immunology, and Thani Jambulingam of Saint Joseph's University examines the fight to control the GLP-1 patient journey.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us